Revenio Group Oyj (LON:0KFH)
London
· Delayed Price · Currency is GBP · Price in EUR 24.00
0.00 (0.00%)
At close: Apr 14, 2025
Revenio Group Oyj Revenue
In the year 2024, Revenio Group Oyj had annual revenue of 103.82M EUR with 7.27% growth. Revenio Group Oyj had revenue of 30.72M in the quarter ending December 31, 2024, with 4.54% growth.
Revenue
103.82M EUR
Revenue Growth
+7.27%
P/S Ratio
6.24
Revenue / Employee
430.79K EUR
Employees
241
Market Cap
535.86M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 103.82M | 7.04M | 7.27% |
| Dec 31, 2023 | 96.79M | -445.00K | -0.46% |
| Dec 31, 2022 | 97.23M | 17.88M | 22.53% |
| Dec 31, 2021 | 79.36M | 18.04M | 29.43% |
| Dec 31, 2020 | 61.31M | 11.60M | 23.34% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |